OTC healthcare in the United Kingdom
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
Table 1 Retail Sales of Homoeopathy 1998-2003
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 2 Consumer Expenditure on Health Goods and Medical Services 1999-2004
2.11 Life Expectancy
Table 3 Life Expectancy at Birth 1999-2004
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 4 Sales of OTC Healthcare by Sector: Value 1999-2004
Table 5 Sales of OTC Healthcare by Sector: % Value Growth 1999-2004
3.2 Switches
Summary 1 OTC Healthcare Switches 2004-2005
3.3 Key Trends and Developments
3.4 Competitive Environment
Table 6 OTC Healthcare Company Shares 2001-2004
Table 7 OTC Healthcare Brand Shares 2001-2004
3.5 Leading Company Profiles β Bayer Plc
Summary 2 Bayer AG Operational Indicators 2004
Table 8 Bayer Plc Shares of OTC Healthcare by Subsector 2001-2004
3.6 Leading Company Profiles β Boots Healthcare International
Summary 3 Boots HealthCare International Operational Indicators 2005
Table 9 Crookes Healthcare Ltd Shares of OTC Healthcare by Subsector 2001-2004
Table 10 Boots Plc Shares of OTC Healthcare by Subsector 2001-2004
3.7 Leading Company Profiles β GlaxoSmithKline Plc
Summary 4 GlaxoSmithKline Operational Indicators 2004
Table 11 GlaxoSmithKline Plc Shares of OTC Healthcare by Subsector 2001-2004
3.8 Leading Company Profiles β Johnson & Johnson MSD Ltd
Summary 5 Johnson & Johnson Inc Operational Indicators 2004
Table 12 Johnson & Johnson MSD Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.9 Leading Company Profiles β Novartis Pharmaceuticals UK Ltd
Summary 6 Novartis AG Operational Indicators 2004
Table 13 Novartis Pharmaceuticals UK Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.10 Leading Company Profiles β Pfizer Consumer Healthcare Ltd
Summary 7 Pfizer Inc Operational Indicators 2004
Table 14 Pfizer Consumer Healthcare Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.11 Leading Company Profiles β Reckitt Benckiser Plc
Summary 8 Reckitt Benckiser UK Ltd Operational Indicators 2004
Table 15 Reckitt Benckiser Plc Shares of OTC Healthcare by Subsector 2001-2004
3.12 Leading Company Profiles β Roche Products Ltd
Summary 9 Roche Holding AG Operational Indicators 2004
Table 16 Roche Products Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.13 Leading Company Profiles β Seven Seas Ltd
Table 17 Seven Seas Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.14 Leading Company Profiles β SSL International Plc
Table 18 SSL International Shares of OTC Healthcare by Subsector 2001-2004
3.15 Leading Company Profiles β Wyeth Consumer Healthcare
Summary 10 Wyeth Consumer Healthcare Operational Indicators 2004
Table 19 Wyeth Consumer Healthcare Shares of OTC Healthcare by Subsector 2001-2004
3.16 Emerging and Niche Companies
3.17 Retail Distribution
Table 20 Sales of OTC Healthcare by Distribution Format: % Analysis 1999/2004
Table 21 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2004
3.18 Retailer Activity and Private Label Trends
Table 22 Penetration of Private Label by Sector 2001-2004
3.19 Forecast Market Performance
Table 23 Forecast Sales of OTC Healthcare by Sector: Value 2004-2009
Table 24 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2004-2009
4. WOUND TREATMENTS SALES
4.1 Sector Performance
Table 25 Sales of Wound Treatments by Subsector: Value 1999-2004
Table 26 Sales of Wound Treatments by Subsector: % Value Growth 1999-2004
Table 27 Wound Treatments Company Shares 2001-2004
Table 28 Wound Treatments Brand Shares 2001-2004
Table 29 Forecast Sales of Wound Treatments by Subsector: Value 2004-2009
Table 30 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
4.2 New Product Developments
Summary 11 Wound Treatment Products: New Product Launches 2003
5. DEFINITIONS